○Ingrid E Scheffer (Paediatrics, University of Melbourne/Austin Health, Australia)
セッション情報
共催シンポジウム
[JS2] JSCN‒ISS Joint Symposium:Overview of the latest development in developmental and epileptic encephalopathy (DEE)
2024年6月1日(土) 10:10 〜 11:40 第1会場 (1号館 2F センチュリーホール)
座長:Raman Sanker(University of California, Los Angels),山内 秀雄(埼玉医科大学 病院小児科)
In 2022, the International League Against Epilepsy (ILAE) released the new classification and definition of electroclinically-defined epilepsy syndromes with onset in neonates, infancy, and childhood. Here, developmental and epileptic encephalopathy (DEE) was defined as developmental impairment-associated epilepsy due to the underlying etiology and abundant epileptiform activity. DEE includes early infantile DEE, epilepsy of infancy with migrating focal seizures, infantile epileptic spasm syndrome, Dravet syndrome, epilepsy with myoclonic-atonic seizures, Lennox–Gastaut syndrome, and DEE with spike-wave activation in sleep, and others. In this symposium, four experts of pediatric epilepsy will present the overview of the latest development in DEE, focusing on genetic etiology, neuroimaging, anti-seizure medication, and surgical treatment. This symposium aims to provide the recent findings and develop the future clinical practice and research about DEE.
○伊藤 祐史 (名古屋大学大学院医学系研究科小児科)
○Wang‒Tso Lee (National Taiwan University Children’s Hospital/National Taiwan University College of Medicine)
○本田 涼子1, 小野 智憲2, 戸田 啓介3, 池田 憲呼1, 西口 奈菜子1, 安 忠輝1, 馬場 啓至4 (1.NHO長崎医療センター小児科, 2.NHO長崎医療センター脳神経外科, 3.NHO長崎川棚医療センター脳神経外科, 4.西諫早病院脳神経外科)